Earlier studies have described PSAP expression in 0–11% of pancreatic neuroendocrine tumors [17,30], while two studies failed to find PSAP expression in gastric adenocarcinomas [30,31]. The gene discussed is PSAP; the disease is pancreatic neuroendocrine tumor.